[日本語] English
万見
- PDB-1pis: SOLUTION STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 -

+
データを開く


IDまたはキーワード:

読み込み中...

-
基本情報

登録情報
データベース: PDB / ID: 1pis
タイトルSOLUTION STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2
要素PHOSPHOLIPASE A2
キーワードCARBOXYLIC ESTER HYDROLASE / PHOSPHOLIPASE A2 / PHOSPHATIDE-2-ACYL-HYDROLASE / PLA2
機能・相同性
機能・相同性情報


positive regulation of podocyte apoptotic process / regulation of D-glucose import / phospholipase A2 activity / phosphatidylglycerol metabolic process / phosphatidylcholine metabolic process / leukotriene biosynthetic process / neutrophil mediated immunity / phospholipase A2 / bile acid binding / calcium-dependent phospholipase A2 activity ...positive regulation of podocyte apoptotic process / regulation of D-glucose import / phospholipase A2 activity / phosphatidylglycerol metabolic process / phosphatidylcholine metabolic process / leukotriene biosynthetic process / neutrophil mediated immunity / phospholipase A2 / bile acid binding / calcium-dependent phospholipase A2 activity / positive regulation of calcium ion transport into cytosol / lipid catabolic process / neutrophil chemotaxis / positive regulation of MAP kinase activity / positive regulation of interleukin-8 production / positive regulation of immune response / phospholipid binding / cellular response to insulin stimulus / positive regulation of fibroblast proliferation / fatty acid biosynthetic process / positive regulation of MAPK cascade / intracellular signal transduction / signaling receptor binding / positive regulation of cell population proliferation / calcium ion binding / cell surface / positive regulation of transcription by RNA polymerase II / extracellular region
類似検索 - 分子機能
Phospholipase A2, aspartic acid active site / Phospholipase A2 aspartic acid active site. / Phospholipase A2 / Phospholipase A2 / Phospholipase A2, histidine active site / Phospholipase A2 histidine active site. / Phospholipase A2 domain / Phospholipase A2 / Phospholipase A2 / Phospholipase A2 domain ...Phospholipase A2, aspartic acid active site / Phospholipase A2 aspartic acid active site. / Phospholipase A2 / Phospholipase A2 / Phospholipase A2, histidine active site / Phospholipase A2 histidine active site. / Phospholipase A2 domain / Phospholipase A2 / Phospholipase A2 / Phospholipase A2 domain / Phospholipase A2 domain superfamily / Up-down Bundle / Mainly Alpha
類似検索 - ドメイン・相同性
Phospholipase A2, major isoenzyme
類似検索 - 構成要素
生物種Sus scrofa (ブタ)
手法溶液NMR
データ登録者Van Den Berg, B.D. / Tessari, M. / De Haas, G.H. / Verheij, H.M. / Boelens, R. / Kaptein, R.
引用ジャーナル: EMBO J. / 年: 1995
タイトル: Solution structure of porcine pancreatic phospholipase A2.
著者: van den Berg, B. / Tessari, M. / de Haas, G.H. / Verheij, H.M. / Boelens, R. / Kaptein, R.
履歴
登録1994年12月22日処理サイト: BNL
改定 1.01995年6月3日Provider: repository / タイプ: Initial release
改定 1.12008年3月24日Group: Version format compliance
改定 1.22011年7月13日Group: Version format compliance
改定 1.32022年2月23日Group: Database references / Derived calculations / Other
カテゴリ: database_2 / pdbx_database_status ...database_2 / pdbx_database_status / pdbx_struct_assembly / pdbx_struct_conn_angle / pdbx_struct_oper_list / struct_conn / struct_site
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession ..._database_2.pdbx_DOI / _database_2.pdbx_database_accession / _pdbx_database_status.process_site / _pdbx_struct_conn_angle.ptnr1_auth_comp_id / _pdbx_struct_conn_angle.ptnr1_auth_seq_id / _pdbx_struct_conn_angle.ptnr1_label_atom_id / _pdbx_struct_conn_angle.ptnr1_label_comp_id / _pdbx_struct_conn_angle.ptnr1_label_seq_id / _pdbx_struct_conn_angle.ptnr3_auth_comp_id / _pdbx_struct_conn_angle.ptnr3_auth_seq_id / _pdbx_struct_conn_angle.ptnr3_label_atom_id / _pdbx_struct_conn_angle.ptnr3_label_comp_id / _pdbx_struct_conn_angle.ptnr3_label_seq_id / _pdbx_struct_conn_angle.value / _struct_conn.pdbx_dist_value / _struct_conn.ptnr1_auth_comp_id / _struct_conn.ptnr1_auth_seq_id / _struct_conn.ptnr1_label_asym_id / _struct_conn.ptnr1_label_atom_id / _struct_conn.ptnr1_label_comp_id / _struct_conn.ptnr1_label_seq_id / _struct_conn.ptnr2_auth_comp_id / _struct_conn.ptnr2_auth_seq_id / _struct_conn.ptnr2_label_asym_id / _struct_conn.ptnr2_label_atom_id / _struct_conn.ptnr2_label_comp_id / _struct_conn.ptnr2_label_seq_id / _struct_site.pdbx_auth_asym_id / _struct_site.pdbx_auth_comp_id / _struct_site.pdbx_auth_seq_id
改定 1.42024年11月13日Group: Data collection / Structure summary
カテゴリ: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / pdbx_entry_details / pdbx_modification_feature

-
構造の表示

構造ビューア分子:
MolmilJmol/JSmol

ダウンロードとリンク

-
集合体

登録構造単位
A: PHOSPHOLIPASE A2
ヘテロ分子


分子量 (理論値)分子数
合計 (水以外)14,0502
ポリマ－14,0101
非ポリマー401
水00
1


  • 登録構造と同一
  • 登録者が定義した集合体
タイプ名称対称操作数
identity operation1_555x,y,z1
Atom site foot note1: GLN 4 - PHE 5 MODEL 1 OMEGA = 148.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
2: VAL 38 - ASP 39 MODEL 1 OMEGA = 146.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
3: LEU 41 - ASP 42 MODEL 1 OMEGA = 143.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
4: ASN 57 - LEU 58 MODEL 1 OMEGA = 216.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
5: LYS 62 - PHE 63 MODEL 1 OMEGA = 211.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
6: PHE 63 - LEU 64 MODEL 1 OMEGA = 138.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
7: CYS 77 - SER 78 MODEL 1 OMEGA = 130.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
8: ASN 79 - THR 80 MODEL 1 OMEGA = 89.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
9: ASN 85 - SER 86 MODEL 1 OMEGA = 217.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
10: SER 86 - LYS 87 MODEL 1 OMEGA = 148.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
11: LYS 87 - ASN 88 MODEL 1 OMEGA = 213.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
12: ALA 109 - PRO 110 MODEL 1 OMEGA = 149.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
13: LYS 113 - GLU 114 MODEL 1 OMEGA = 228.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
14: ASP 119 - THR 120 MODEL 1 OMEGA = 217.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
15: THR 120 - LYS 121 MODEL 1 OMEGA = 127.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
16: LYS 122 - TYR 123 MODEL 1 OMEGA = 211.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
17: PRO 37 - VAL 38 MODEL 2 OMEGA = 211.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
18: VAL 38 - ASP 39 MODEL 2 OMEGA = 140.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
19: LEU 41 - ASP 42 MODEL 2 OMEGA = 143.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
20: ASN 57 - LEU 58 MODEL 2 OMEGA = 225.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
21: PHE 63 - LEU 64 MODEL 2 OMEGA = 137.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
22: LEU 64 - VAL 65 MODEL 2 OMEGA = 122.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
23: CYS 77 - SER 78 MODEL 2 OMEGA = 133.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
24: ASN 79 - THR 80 MODEL 2 OMEGA = 121.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
25: ASN 85 - SER 86 MODEL 2 OMEGA = 213.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
26: ALA 109 - PRO 110 MODEL 2 OMEGA = 146.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
27: LYS 113 - GLU 114 MODEL 2 OMEGA = 228.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
28: LYS 116 - ASN 117 MODEL 2 OMEGA = 148.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
29: THR 120 - LYS 121 MODEL 2 OMEGA = 125.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
30: ALA 1 - LEU 2 MODEL 3 OMEGA = 126.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
31: LEU 2 - TRP 3 MODEL 3 OMEGA = 219.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
32: LYS 10 - CYS 11 MODEL 3 OMEGA = 139.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
33: VAL 38 - ASP 39 MODEL 3 OMEGA = 146.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
34: LEU 41 - ASP 42 MODEL 3 OMEGA = 140.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
35: ASN 57 - LEU 58 MODEL 3 OMEGA = 215.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
36: PHE 63 - LEU 64 MODEL 3 OMEGA = 131.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
37: CYS 77 - SER 78 MODEL 3 OMEGA = 119.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
38: ASN 79 - THR 80 MODEL 3 OMEGA = 120.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
39: LYS 113 - GLU 114 MODEL 3 OMEGA = 227.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
40: ASP 119 - THR 120 MODEL 3 OMEGA = 216.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
41: THR 120 - LYS 121 MODEL 3 OMEGA = 128.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
42: GLY 35 - THR 36 MODEL 4 OMEGA = 149.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
43: LEU 41 - ASP 42 MODEL 4 OMEGA = 142.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
44: ASN 57 - LEU 58 MODEL 4 OMEGA = 243.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
45: PHE 63 - LEU 64 MODEL 4 OMEGA = 148.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
46: LEU 64 - VAL 65 MODEL 4 OMEGA = 240.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
47: CYS 77 - SER 78 MODEL 4 OMEGA = 127.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
48: ASN 79 - THR 80 MODEL 4 OMEGA = 123.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
49: ASN 85 - SER 86 MODEL 4 OMEGA = 224.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
50: LYS 87 - ASN 88 MODEL 4 OMEGA = 214.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
51: LYS 113 - GLU 114 MODEL 4 OMEGA = 217.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
52: ASP 119 - THR 120 MODEL 4 OMEGA = 216.38 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
53: THR 120 - LYS 121 MODEL 4 OMEGA = 129.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
54: GLN 4 - PHE 5 MODEL 5 OMEGA = 135.37 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
55: ARG 6 - SER 7 MODEL 5 OMEGA = 147.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
56: VAL 38 - ASP 39 MODEL 5 OMEGA = 147.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
57: LEU 41 - ASP 42 MODEL 5 OMEGA = 143.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
58: ASN 57 - LEU 58 MODEL 5 OMEGA = 218.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
59: LEU 64 - VAL 65 MODEL 5 OMEGA = 282.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
60: CYS 77 - SER 78 MODEL 5 OMEGA = 129.73 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
61: ASN 79 - THR 80 MODEL 5 OMEGA = 113.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
62: ASN 85 - SER 86 MODEL 5 OMEGA = 224.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
63: SER 86 - LYS 87 MODEL 5 OMEGA = 148.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
64: LYS 87 - ASN 88 MODEL 5 OMEGA = 211.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
65: ALA 109 - PRO 110 MODEL 5 OMEGA = 149.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
66: LYS 113 - GLU 114 MODEL 5 OMEGA = 228.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
67: ASP 119 - THR 120 MODEL 5 OMEGA = 213.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
68: THR 120 - LYS 121 MODEL 5 OMEGA = 125.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
69: ALA 1 - LEU 2 MODEL 6 OMEGA = 148.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
70: GLN 4 - PHE 5 MODEL 6 OMEGA = 145.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
71: GLY 35 - THR 36 MODEL 6 OMEGA = 148.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
72: LEU 41 - ASP 42 MODEL 6 OMEGA = 144.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
73: ASN 57 - LEU 58 MODEL 6 OMEGA = 213.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
74: PHE 63 - LEU 64 MODEL 6 OMEGA = 128.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
75: CYS 77 - SER 78 MODEL 6 OMEGA = 131.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
76: ASN 79 - THR 80 MODEL 6 OMEGA = 121.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
77: ASN 85 - SER 86 MODEL 6 OMEGA = 211.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
78: ALA 109 - PRO 110 MODEL 6 OMEGA = 144.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
79: LYS 113 - GLU 114 MODEL 6 OMEGA = 217.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
80: ASP 119 - THR 120 MODEL 6 OMEGA = 216.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
81: THR 120 - LYS 121 MODEL 6 OMEGA = 128.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
82: VAL 38 - ASP 39 MODEL 7 OMEGA = 149.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
83: LEU 41 - ASP 42 MODEL 7 OMEGA = 143.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
84: ASN 57 - LEU 58 MODEL 7 OMEGA = 224.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
85: PHE 63 - LEU 64 MODEL 7 OMEGA = 132.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
86: CYS 77 - SER 78 MODEL 7 OMEGA = 119.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
87: ASN 79 - THR 80 MODEL 7 OMEGA = 117.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
88: ASN 85 - SER 86 MODEL 7 OMEGA = 224.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
89: SER 86 - LYS 87 MODEL 7 OMEGA = 147.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
90: LYS 87 - ASN 88 MODEL 7 OMEGA = 213.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
91: ALA 109 - PRO 110 MODEL 7 OMEGA = 144.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
92: LYS 113 - GLU 114 MODEL 7 OMEGA = 218.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
93: ASP 119 - THR 120 MODEL 7 OMEGA = 216.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
94: THR 120 - LYS 121 MODEL 7 OMEGA = 140.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
95: LYS 121 - LYS 122 MODEL 7 OMEGA = 234.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
96: ALA 1 - LEU 2 MODEL 8 OMEGA = 126.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
97: LEU 2 - TRP 3 MODEL 8 OMEGA = 215.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
98: LYS 10 - CYS 11 MODEL 8 OMEGA = 139.37 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
99: VAL 38 - ASP 39 MODEL 8 OMEGA = 148.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
100: LEU 41 - ASP 42 MODEL 8 OMEGA = 145.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
101: ASN 57 - LEU 58 MODEL 8 OMEGA = 236.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
102: PHE 63 - LEU 64 MODEL 8 OMEGA = 148.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
103: LEU 64 - VAL 65 MODEL 8 OMEGA = 235.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
104: CYS 77 - SER 78 MODEL 8 OMEGA = 123.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
105: ASN 79 - THR 80 MODEL 8 OMEGA = 125.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
106: ASN 85 - SER 86 MODEL 8 OMEGA = 227.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
107: SER 86 - LYS 87 MODEL 8 OMEGA = 146.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
108: LYS 113 - GLU 114 MODEL 8 OMEGA = 228.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
109: ASP 119 - THR 120 MODEL 8 OMEGA = 214.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
110: THR 120 - LYS 121 MODEL 8 OMEGA = 125.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
111: GLN 4 - PHE 5 MODEL 9 OMEGA = 137.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
112: ARG 6 - SER 7 MODEL 9 OMEGA = 142.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
113: THR 36 - PRO 37 MODEL 9 OMEGA = 141.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
114: VAL 38 - ASP 39 MODEL 9 OMEGA = 147.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
115: LEU 41 - ASP 42 MODEL 9 OMEGA = 142.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
116: ASN 57 - LEU 58 MODEL 9 OMEGA = 217.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
117: LEU 64 - VAL 65 MODEL 9 OMEGA = 118.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
118: CYS 77 - SER 78 MODEL 9 OMEGA = 130.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
119: ASN 79 - THR 80 MODEL 9 OMEGA = 90.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
120: ALA 109 - PRO 110 MODEL 9 OMEGA = 145.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
121: LYS 113 - GLU 114 MODEL 9 OMEGA = 216.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
122: ASN 117 - LEU 118 MODEL 9 OMEGA = 210.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
123: ASP 119 - THR 120 MODEL 9 OMEGA = 216.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
124: THR 120 - LYS 121 MODEL 9 OMEGA = 127.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
125: LYS 122 - TYR 123 MODEL 9 OMEGA = 211.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
126: VAL 38 - ASP 39 MODEL 10 OMEGA = 149.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
127: LEU 41 - ASP 42 MODEL 10 OMEGA = 143.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
128: ASN 57 - LEU 58 MODEL 10 OMEGA = 215.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
129: LYS 62 - PHE 63 MODEL 10 OMEGA = 210.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
130: PHE 63 - LEU 64 MODEL 10 OMEGA = 131.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
131: CYS 77 - SER 78 MODEL 10 OMEGA = 137.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
132: ASN 79 - THR 80 MODEL 10 OMEGA = 98.09 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
133: LYS 113 - GLU 114 MODEL 10 OMEGA = 224.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
134: ASP 119 - THR 120 MODEL 10 OMEGA = 213.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
135: THR 120 - LYS 121 MODEL 10 OMEGA = 124.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
136: LEU 2 - TRP 3 MODEL 11 OMEGA = 147.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
137: VAL 38 - ASP 39 MODEL 11 OMEGA = 149.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
138: LEU 41 - ASP 42 MODEL 11 OMEGA = 144.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
139: LYS 56 - ASN 57 MODEL 11 OMEGA = 149.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
140: ASN 57 - LEU 58 MODEL 11 OMEGA = 134.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
141: PHE 63 - LEU 64 MODEL 11 OMEGA = 128.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
142: CYS 77 - SER 78 MODEL 11 OMEGA = 132.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
143: ASN 79 - THR 80 MODEL 11 OMEGA = 120.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
144: ASN 85 - SER 86 MODEL 11 OMEGA = 211.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
145: ALA 109 - PRO 110 MODEL 11 OMEGA = 145.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
146: LYS 113 - GLU 114 MODEL 11 OMEGA = 217.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
147: ASN 117 - LEU 118 MODEL 11 OMEGA = 211.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
148: ASP 119 - THR 120 MODEL 11 OMEGA = 221.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
149: THR 120 - LYS 121 MODEL 11 OMEGA = 129.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
150: ALA 1 - LEU 2 MODEL 12 OMEGA = 253.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
151: LYS 10 - CYS 11 MODEL 12 OMEGA = 135.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
152: LEU 41 - ASP 42 MODEL 12 OMEGA = 144.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
153: ASN 57 - LEU 58 MODEL 12 OMEGA = 221.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
154: LEU 64 - VAL 65 MODEL 12 OMEGA = 234.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
155: CYS 77 - SER 78 MODEL 12 OMEGA = 127.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
156: ASN 79 - THR 80 MODEL 12 OMEGA = 118.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
157: ASN 85 - SER 86 MODEL 12 OMEGA = 218.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
158: ALA 109 - PRO 110 MODEL 12 OMEGA = 148.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
159: ASN 112 - LYS 113 MODEL 12 OMEGA = 147.73 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
160: ASN 117 - LEU 118 MODEL 12 OMEGA = 210.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
161: ASP 119 - THR 120 MODEL 12 OMEGA = 218.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
162: THR 120 - LYS 121 MODEL 12 OMEGA = 128.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
163: LYS 122 - TYR 123 MODEL 12 OMEGA = 211.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
164: GLN 4 - PHE 5 MODEL 13 OMEGA = 146.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
165: GLY 35 - THR 36 MODEL 13 OMEGA = 144.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
166: LEU 41 - ASP 42 MODEL 13 OMEGA = 141.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
167: ASN 57 - LEU 58 MODEL 13 OMEGA = 222.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
168: LEU 64 - VAL 65 MODEL 13 OMEGA = 235.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
169: CYS 77 - SER 78 MODEL 13 OMEGA = 132.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
170: ASN 79 - THR 80 MODEL 13 OMEGA = 80.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
171: ASN 85 - SER 86 MODEL 13 OMEGA = 217.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
172: ALA 109 - PRO 110 MODEL 13 OMEGA = 145.47 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
173: LYS 113 - GLU 114 MODEL 13 OMEGA = 228.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
174: LYS 116 - ASN 117 MODEL 13 OMEGA = 149.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
175: ASP 119 - THR 120 MODEL 13 OMEGA = 217.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
176: THR 120 - LYS 121 MODEL 13 OMEGA = 128.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
177: GLY 35 - THR 36 MODEL 14 OMEGA = 148.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
178: VAL 38 - ASP 39 MODEL 14 OMEGA = 148.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
179: LEU 41 - ASP 42 MODEL 14 OMEGA = 144.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
180: ASN 57 - LEU 58 MODEL 14 OMEGA = 214.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
181: PHE 63 - LEU 64 MODEL 14 OMEGA = 125.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
182: CYS 77 - SER 78 MODEL 14 OMEGA = 117.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
183: ASN 79 - THR 80 MODEL 14 OMEGA = 117.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
184: ASN 85 - SER 86 MODEL 14 OMEGA = 221.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
185: SER 86 - LYS 87 MODEL 14 OMEGA = 149.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
186: LYS 87 - ASN 88 MODEL 14 OMEGA = 213.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
187: ALA 109 - PRO 110 MODEL 14 OMEGA = 147.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
188: LYS 113 - GLU 114 MODEL 14 OMEGA = 225.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
189: ASP 119 - THR 120 MODEL 14 OMEGA = 214.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
190: THR 120 - LYS 121 MODEL 14 OMEGA = 140.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
191: LYS 121 - LYS 122 MODEL 14 OMEGA = 223.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
192: ALA 1 - LEU 2 MODEL 15 OMEGA = 117.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
193: LEU 2 - TRP 3 MODEL 15 OMEGA = 211.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
194: GLN 4 - PHE 5 MODEL 15 OMEGA = 140.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
195: ARG 6 - SER 7 MODEL 15 OMEGA = 140.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
196: LEU 41 - ASP 42 MODEL 15 OMEGA = 145.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
197: ASN 57 - LEU 58 MODEL 15 OMEGA = 212.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
198: PHE 63 - LEU 64 MODEL 15 OMEGA = 126.49 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
199: CYS 77 - SER 78 MODEL 15 OMEGA = 121.38 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
200: ASN 79 - THR 80 MODEL 15 OMEGA = 115.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
201: ASN 85 - SER 86 MODEL 15 OMEGA = 222.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
202: LYS 87 - ASN 88 MODEL 15 OMEGA = 213.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
203: ALA 109 - PRO 110 MODEL 15 OMEGA = 145.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
204: LYS 113 - GLU 114 MODEL 15 OMEGA = 215.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
205: ASN 117 - LEU 118 MODEL 15 OMEGA = 210.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
206: ASP 119 - THR 120 MODEL 15 OMEGA = 216.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
207: THR 120 - LYS 121 MODEL 15 OMEGA = 129.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
208: GLY 35 - THR 36 MODEL 16 OMEGA = 148.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
209: LEU 41 - ASP 42 MODEL 16 OMEGA = 144.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
210: ASN 57 - LEU 58 MODEL 16 OMEGA = 214.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
211: PHE 63 - LEU 64 MODEL 16 OMEGA = 127.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
212: CYS 77 - SER 78 MODEL 16 OMEGA = 245.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
213: SER 78 - ASN 79 MODEL 16 OMEGA = 136.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
214: ASN 79 - THR 80 MODEL 16 OMEGA = 111.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
215: ASN 85 - SER 86 MODEL 16 OMEGA = 219.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
216: ALA 109 - PRO 110 MODEL 16 OMEGA = 148.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
217: LYS 113 - GLU 114 MODEL 16 OMEGA = 218.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
218: ASP 119 - THR 120 MODEL 16 OMEGA = 212.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
219: THR 120 - LYS 121 MODEL 16 OMEGA = 232.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
220: LYS 10 - CYS 11 MODEL 17 OMEGA = 148.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
221: GLY 35 - THR 36 MODEL 17 OMEGA = 146.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
222: VAL 38 - ASP 39 MODEL 17 OMEGA = 148.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
223: LEU 41 - ASP 42 MODEL 17 OMEGA = 143.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
224: CYS 45 - GLU 46 MODEL 17 OMEGA = 144.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
225: ASN 57 - LEU 58 MODEL 17 OMEGA = 217.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
226: PHE 63 - LEU 64 MODEL 17 OMEGA = 129.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
227: ASN 79 - THR 80 MODEL 17 OMEGA = 122.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
228: ASN 85 - SER 86 MODEL 17 OMEGA = 216.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
229: ALA 109 - PRO 110 MODEL 17 OMEGA = 146.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
230: LYS 113 - GLU 114 MODEL 17 OMEGA = 218.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
231: ASP 119 - THR 120 MODEL 17 OMEGA = 212.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
232: THR 120 - LYS 121 MODEL 17 OMEGA = 234.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
233: ARG 6 - SER 7 MODEL 18 OMEGA = 137.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
234: LEU 41 - ASP 42 MODEL 18 OMEGA = 142.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
235: ASN 57 - LEU 58 MODEL 18 OMEGA = 220.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
236: LEU 64 - VAL 65 MODEL 18 OMEGA = 115.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
237: CYS 77 - SER 78 MODEL 18 OMEGA = 114.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
238: ASN 79 - THR 80 MODEL 18 OMEGA = 119.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
239: ASN 85 - SER 86 MODEL 18 OMEGA = 216.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
240: ASN 101 - ALA 102 MODEL 18 OMEGA = 148.76 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
241: ASN 112 - LYS 113 MODEL 18 OMEGA = 148.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
242: LYS 116 - ASN 117 MODEL 18 OMEGA = 149.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
243: ASP 119 - THR 120 MODEL 18 OMEGA = 216.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
244: THR 120 - LYS 121 MODEL 18 OMEGA = 128.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
245: ALA 1 - LEU 2 MODEL 19 OMEGA = 126.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
246: LEU 2 - TRP 3 MODEL 19 OMEGA = 219.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
247: LYS 10 - CYS 11 MODEL 19 OMEGA = 143.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
248: VAL 38 - ASP 39 MODEL 19 OMEGA = 149.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
249: LEU 41 - ASP 42 MODEL 19 OMEGA = 140.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
250: ASN 57 - LEU 58 MODEL 19 OMEGA = 221.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
251: PHE 63 - LEU 64 MODEL 19 OMEGA = 131.74 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
252: CYS 77 - SER 78 MODEL 19 OMEGA = 127.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
253: ASN 79 - THR 80 MODEL 19 OMEGA = 119.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
254: ASN 85 - SER 86 MODEL 19 OMEGA = 211.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
255: ALA 109 - PRO 110 MODEL 19 OMEGA = 149.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
256: LYS 113 - GLU 114 MODEL 19 OMEGA = 218.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
257: ASP 119 - THR 120 MODEL 19 OMEGA = 220.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
258: THR 120 - LYS 121 MODEL 19 OMEGA = 127.74 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
259: LYS 122 - TYR 123 MODEL 19 OMEGA = 211.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
260: VAL 38 - ASP 39 MODEL 20 OMEGA = 149.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
261: LEU 41 - ASP 42 MODEL 20 OMEGA = 136.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
262: ASN 57 - LEU 58 MODEL 20 OMEGA = 223.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
263: PHE 63 - LEU 64 MODEL 20 OMEGA = 133.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
264: CYS 77 - SER 78 MODEL 20 OMEGA = 127.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
265: ASN 79 - THR 80 MODEL 20 OMEGA = 117.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
266: ASN 85 - SER 86 MODEL 20 OMEGA = 219.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
267: LYS 87 - ASN 88 MODEL 20 OMEGA = 223.67 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
268: ALA 109 - PRO 110 MODEL 20 OMEGA = 145.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
269: ASN 112 - LYS 113 MODEL 20 OMEGA = 149.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
270: ASP 119 - THR 120 MODEL 20 OMEGA = 216.67 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
271: THR 120 - LYS 121 MODEL 20 OMEGA = 128.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
NMR アンサンブル
データ基準
コンフォーマー数 (登録 / 計算)20 / -
代表モデル

-
要素

#1: タンパク質 PHOSPHOLIPASE A2


分子量: 14009.714 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現) Sus scrofa (ブタ) / 器官: PANCREAS / 参照: UniProt: P00592, phospholipase A2
#2: 化合物 ChemComp-CA / CALCIUM ION / カルシウムジカチオン


分子量: 40.078 Da / 分子数: 1 / 由来タイプ: 合成 / 式: Ca
Has protein modificationY

-
実験情報

-
実験

実験手法: 溶液NMR

-
試料調製

結晶化
*PLUS
手法: other

-
解析

NMRアンサンブル登録したコンフォーマーの数: 20

+
万見について

-
お知らせ

-
2022年2月9日: EMDBエントリの付随情報ファイルのフォーマットが新しくなりました

EMDBエントリの付随情報ファイルのフォーマットが新しくなりました

  • EMDBのヘッダファイルのバージョン3が、公式のフォーマットとなりました。
  • これまでは公式だったバージョン1.9は、アーカイブから削除されます。

関連情報:EMDBヘッダ

外部リンク:wwPDBはEMDBデータモデルのバージョン3へ移行します

-
2020年8月12日: 新型コロナ情報

新型コロナ情報

URL: https://pdbj.org/emnavi/covid19.php

新ページ: EM Navigatorに新型コロナウイルスの特設ページを開設しました。

関連情報:Covid-19情報 / 2020年3月5日: 新型コロナウイルスの構造データ

+
2020年3月5日: 新型コロナウイルスの構造データ

新型コロナウイルスの構造データ

関連情報:万見生物種 / 2020年8月12日: 新型コロナ情報

外部リンク:COVID-19特集ページ - PDBj / 今月の分子2020年2月：コロナウイルスプロテーアーゼ

+
2019年1月31日: EMDBのIDの桁数の変更

EMDBのIDの桁数の変更

  • EMDBエントリに付与されているアクセスコード(EMDB-ID)は4桁の数字(例、EMD-1234)でしたが、間もなく枯渇します。これまでの4桁のID番号は4桁のまま変更されませんが、4桁の数字を使い切った後に発行されるIDは5桁以上の数字(例、EMD-12345)になります。5桁のIDは2019年の春頃から発行される見通しです。
  • EM Navigator/万見では、接頭語「EMD-」は省略されています。

関連情報:Q: 「EMD」とは何ですか？ / 万見/EM NavigatorにおけるID/アクセスコードの表記

外部リンク:EMDB Accession Codes are Changing Soon! / PDBjへお問い合わせ

+
2017年7月12日: PDB大規模アップデート

PDB大規模アップデート

  • 新バージョンのPDBx/mmCIF辞書形式に基づくデータがリリースされました。
  • 今回の更新はバージョン番号が4から5になる大規模なもので、全エントリデータの書き換えが行われる「Remediation」というアップデートに該当します。
  • このバージョンアップで、電子顕微鏡の実験手法に関する多くの項目の書式が改定されました(例：em_softwareなど)。
  • EM NavigatorとYorodumiでも、この改定に基づいた表示内容になります。

外部リンク:wwPDB Remediation / OneDepデータ基準に準拠した、より強化された内容のモデル構造ファイルが、PDBアーカイブで公開されました。

-
万見 (Yorodumi)

幾万の構造データを、幾万の視点から

  • 万見(Yorodumi)は、EMDB/PDB/SASBDBなどの構造データを閲覧するためのページです。
  • EM Navigatorの詳細ページの後継、Omokage検索のフロントエンドも兼ねています。

関連情報:EMDB / PDB / SASBDB / 3つのデータバンクの比較 / 万見検索 / 2016年8月31日: 新しいEM Navigatorと万見 / 万見文献 / Jmol/JSmol / 機能・相同性情報 / 新しいEM Navigatorと万見の変更点

他の情報も見る